Tuberculosis News and Research

Latest Tuberculosis News and Research

TB bacteria produce fatty acid that triggers a pain-response cough to spread the disease

Tuberculosis is distinguished primarily by the persistent cough that serves to spread the disease. Stopping whatever triggers that cough could greatly reduce the transmission of the disease, which annually kills more than 1.3 million people worldwide.

7 Mar 2020

USask researchers receive almost $1 million to fight new coronavirus

A University of Saskatchewan research team and collaborating scientists from across the country have been awarded almost $1 million over two years to develop animal models and test vaccine candidates for effectiveness and safety against the new coronavirus (SARS-CoV-2).

7 Mar 2020

Molecule-sized drills can target diseased cells and kill them in minutes

Molecule-sized drills do the damage they are designed to do. That's bad news for disease.

5 Mar 2020

Tuberculosis bacteria facilitate their spread by producing a molecule that triggers cough

The bacteria that cause the deadly lung disease tuberculosis appear to facilitate their own spread by producing a molecule that triggers cough, a new study led by UTSW researchers shows.

5 Mar 2020

New approach may lead to targeted treatments for certain macrophages or their mechanisms

Can phagocytes act like a Trojan horse, transporting tumour cells within themselves and thereby causing metastases in cancer patients?

5 Mar 2020

UAB research reveals hydrogen sulfide as new culprit for deadly tuberculosis

A new culprit -- hydrogen sulfide -- has been found for the deadly infectious disease tuberculosis. Hydrogen sulfide gas is known for its rotten egg smell, yet it has normal physiological roles in the human body to communicate among cells.

3 Mar 2020

Updated USPSTF recommendations on hepatitis C screening

The U.S. Preventive Services Task Force (USPSTF) now recommends the hepatitis C virus (HCV) infection screening for adults in the age group 18 to 79 years. This update comes against the background of increasing HCV over the last ten years, primarily due to higher injection drug use, and closer monitoring. The recommendation ensures that this screening will be covered by insurance as well without cost-sharing.

2 Mar 2020

Otago researchers involved in world's first trial to prevent TB in people with diabetes

Otago researchers are playing a leadership role in an Euro €4.8 million international project to conduct the world's first trial attempting to prevent tuberculosis in people with diabetes.

27 Feb 2020

Increased numbers of bacterial cells could be associated with anti-microbial resistance

Scientists from the University of Surrey have identified mutations in a gene in an Escherichia coli (E. coli) model that could help explain a form of anti-microbial resistance (AMR) known as 'persistence'.

27 Feb 2020

Researchers identify mechanisms underlying immunotherapy-associated tuberculosis

Researchers at the University of Southampton have identified how new checkpoint inhibitor treatments for cancer can activate tuberculosis in some patients.

24 Feb 2020

New tool incorporates PET and CT scans to measure effectiveness of key anti-TB medicine

Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E.

24 Feb 2020

Artificial Intelligence brings a novel antibiotic compound

Researchers from the Massachusetts Institute of Technology (MIT) have made a scientific breakthrough where their machine-learning algorithm or Artificial Intelligence (AI) program successfully created a novel antibiotic compound. The drug has since then been tested on deadly bacteria in the lab, and in lab mice with a considerable amount of success, explain the researchers. The study results appear in the latest issue of the journal Cell.

20 Feb 2020

Tuberculosis News and Research

Latest Tuberculosis News and Research

TB bacteria produce fatty acid that triggers a pain-response cough to spread the disease

USask researchers receive almost $1 million to fight new coronavirus

Molecule-sized drills can target diseased cells and kill them in minutes

Tuberculosis bacteria facilitate their spread by producing a molecule that triggers cough

New approach may lead to targeted treatments for certain macrophages or their mechanisms

UAB research reveals hydrogen sulfide as new culprit for deadly tuberculosis

Updated USPSTF recommendations on hepatitis C screening

Otago researchers involved in world's first trial to prevent TB in people with diabetes

Increased numbers of bacterial cells could be associated with anti-microbial resistance

Researchers identify mechanisms underlying immunotherapy-associated tuberculosis

New tool incorporates PET and CT scans to measure effectiveness of key anti-TB medicine

Artificial Intelligence brings a novel antibiotic compound

Purdue scientists receive $3.2 million NIH grant to target antimicrobial resistance

Antibiotic resistance poses a growing risk during pandemics

Newly discovered antibiotics kill bacteria differently

Coronavirus tests public health infrastructure in the heartland

Researchers engineer probiotics to safely deliver immunotherapies to tumors

Recent progress in TB diagnostics and prevention approaches offers hope for future

Advanced X-ray combination technique aids tuberculosis and osteoporosis research

UH professor examines life cycle of drug-resistant persister cells in recurrent infections

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Tuberculosis News and Research

Latest Tuberculosis News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in